170494 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants; Selectin superfamily, e.g. LAM-1, GlyCAM, ELAM-1, PADGEM Selectins, e.g. CD62
P-SELECTIN MUTANTS AND MODULATION OF INTEGRIN-MEDIATED SIGNALING
#2METHODS FOR DETECTING A CANCER
#3METHODS RELATING TO IMPAIRED RESPIRATORY HEALTH THERAPEUTICS
#4BLOOD BIOMARKERS IN LONG-COVID-19
#5SYSTEMS, APPARATUSES, AND METHODS TO MEASURE ADHESION OF BLOOD CELLS IN MICROFLUIDIC CHANNELS
#6ASSESSMENT AND DETECTION OF PORTAL VEIN THROMBOSIS IN CHRONIC LIVER DISEASE AND STAGING THEREOF
#7METHOD OF PREDICTING A PATIENT'S BENEFIT FROM THERAPY WITH AN IMMUNE CHECKPOINT INHIBITOR
#8BIOMARKER FOR PREDICTING RESPONSE TO CANCER TREATMENT
#9METHOD FOR DIAGNOSING A PREDISPOSITION OF A LIVING BEING TO DEVELOP THROMBOCYTOPENIA
#10METHODS, COMPOSITIONS, AND KITS FOR DETECTING AND MEASURING ENDOTHELIAL INJURY IN NORMAL AND DISEASED HUMAN CENTRAL NERVOUS SYSTEM (CNS)
#11IMMUNOLOGICAL BIOMARKER FOR PREDICTING CLINICAL EFFECT OF CANCER IMMUNOTHERAPY
#12Recombinant chimeric protein for selectins targeting
#13METHODS FOR USE OF GENE EXPRESSION AS AN INDICATOR OF E-SELECTIN INHIBITOR EFFICACY AND CLINICAL OUTCOME FOR MULTIPLE TUMOR TYPES
#14Immunological biomarker for predicting clinical effect of cancer
#15TEST TO ASSESS LIVER DISEASE SEVERITY
#16MULTI-LAYERED FILTER FOR SEPARATING BLOOD COMPONENTS AND DISEASE DIAGNOSIS KIT USING THE SAME
#17PERIPHERAL BLOOD BIOMARKER FOR EVALUATING ANTI-TUMOR IMMUNE EFFECT OF RADIATION THERAPY
#18LEUKOCYTE RECRUITMENT IN INFECTIOUS DISEASE
#19Immunological biomarker for predicting clinical effect of cancer
#20PROTEIN BIOMARKER PANELS FOR DETECTING COLORECTAL CANCER AND ADVANCED ADENOMA
#21BIOMARKER ASSAY OF NEUROLOGICAL CONDITION
#22Recombinant chimeric protein for selectins targeting
#23Platelet biomarkers and diagnostic methods for vascular diseases
#24ANTIBODIES FOR TARGETING CANCER STEM CELLS AND TREATING AGGRESSIVE CANCERS
#25Method of detecting platelet activating antibodies that cause heparin-induced thrombocytopenia/thrombosis
#26PROTEIN BIOMARKER PANELS FOR DETECTING COLORECTAL CANCER AND ADVANCED ADENOMA
#27Method for determining risk of pre-eclampsia
#28Biomarker-based methods for aiding the diagnosis of stroke
#29P-SELECTIN ASSOCIATED WITH EOSINOPHILS AS A MARKER FOR ASTHMA AND CORRELATING WITH B-1 INTEGRIN ACTIVATION
#30DETECTING PODOCYTE INJURY IN DIABETIC NEPHROPATHY AND GLOMERULONEPHRITIS
#31Protein biomarker panels for detecting colorectal cancer and advanced adenoma
#32Method of detection of platelet-activating antibodies that cause heparin-induced thrombocytopenia/thrombosis
#33Method for aiding differential diagnosis of stroke
#34Peptide MHCII tetramers to detect endogenous calnexin specific CD4 T cells
#35METHODS OR RISK ASSESSMENT OF PML AND RELATED APPARATUS
#36NEW METHODS FOR ISOLATING TR1 CELLS
#37BIOMARKER ASSAY OF NEUROLOGICAL CONDITION
#38P-SELECTIN ASSOCIATED WITH EOSINOPHILS AS A MARKER FOR ASTHMA AND CORRELATING WITH B-1 INTEGRIN ACTIVATION
#39Biomarkers for predicting response to immunosuppressive therapy
#40One step nanosensor for single and multidrug resistance in acute coronary syndrome (ACS)
#41DIAGNOSTIC SUBSTANCE AND METHOD FOR THE DIAGNOSIS OF PROSTATE DISEASES
#42Chemotaxis diagnostic
#43COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ENDOTHELIAL DYSFUNCTION
#44Heparin Compositions and Selectin Inhibition
#45Modulation of T cell recruitment
#46NONSTRUCTURAL PROTEIN NS1 AS A NOVEL THERAPEUTIC TARGET AGAINST FLAVIVIRUSES
#47P-Selectin associated with Eosinophils as a marker for asthma and correlating with B-1 integrin activation
#48Tyrosylprotein sulfotransferases and methods of use thereof
#49METHODS FOR DIAGNOSING AND TREATING HEMOSTATIC DISORDERS BY MODULATING P-SELECTIN ACTIVITY
#50Heparin compositions and selectin inhibition
#51Tyrosylprotein sulfotransferases and methods of use thereof
#52Tyrosylprotein sulfotransferases and methods of use thereof
#53Methods for diagnosing and treating hemostatic disorders by modulating P-selectin activity